Multiple System Atrophy Pipeline Report, 2022 : Insights Into the Current Therapies, Emerging Drugs, and Treatment Outlook | Key Companies β Biogen, Corestem, Theravance, Biohaven Pharma, and Alterity Post author By Post date March 2, 2022